Early cholesterol medicine after heart attack
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial looks at when and how to use cholesterol-lowering treatment soon after a heart attack. It may help people lower LDL (“bad” cholesterol) safely in the first days after an acute event.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old (any sex).
- Your heart attack (STEMI or NSTEMI) must have happened within 48 hours of when symptoms started.
- Your baseline LDL (“bad” cholesterol) must be above a set level (higher if not on steady statins; lower if already taking moderate-intensity statins well).
- You must be willing to join the study and follow study instructions.
- You likely should be able to take statins safely (no known true statin intolerance and no medicines/conditions that block safe statin use).
- You should not already be on high-intensity statins or on statin plus add-on cholesterol drugs like ezetimibe/PCSK9 inhibitors.
- You should not have pregnancy plans for the next 12 months (if you could become pregnant).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether starting a cholesterol-lowering drug called a PCSK9 inhibitor soon after a heart attack can help prevent future blockages. If you had a heart attack, received a stent, and have other arteries with minor blockages, this trial may be for you.
This trial studies whether high-intensity statin plus ezetimibe can improve heart health in people who do not have symptoms but have calcium buildup in their heart arteries. It may help lower cholesterol and reduce future heart risks for the right participants.
This study compares two cholesterol treatment approaches after a heart attack: a lower dose combination versus a higher dose single medicine. It aims to see which option works well and is tolerable for people after a treated heart attack.
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
This trial studies how well long-term cholesterol-lowering treatment works in people who recently had a heart attack (STEMI or NSTEMI). It may help your care team understand which patients benefit most and how treatment should be continued safely.
This trial tests giving strong cholesterol-lowering medicine within 24 hours after a heart attack to see if it helps recovery. It is for people who have had a recent heart attack and are getting a stent placed.
Hear when a new Acute Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.